June 1-6, 2008 - Algarve, Portugal
| Editors: | Barry C. Buckland, Merck & Co., Inc. |
|---|---|
| John G. Auniņš, Merck & Co., Inc. | |
| Paula Marques Alves, ITQB/IBET | |
| Kathrin U. Jansen, Wyeth Vaccine Research |
The articles for these proceedings are not peer-reviewed.
VACCINE TECHNOLOGY II: Conference Program, Barry C. Buckland, John G. Auniņš, Paula Marques Alves, and Kathrin U. Jansen (Article)
Quality Issues: The Good-Enough Vaccine, Philip Minor (Article)
Towards a Therapeutic Hepatitis C Vaccine – a Preclinical and Clinical Learning Curve, Alexander von Gabain (Article)
VEEV Replicon-Based Vaccines Used in Heterologous Prime Boost Strategies Induce Lifelong Protection Against Prostate Cancer and Therapy of Cervical Cancer in Mice and Robust Cell-Mediated Immunity in Rhesus macaques, W. Martin Kast (Article)
FluBlok, A High Dose Recombinant Hemagglutinin Influenza Vaccine, Manon Cox (Article)
Challenges and Solutions for the Next Generation of Vaccines: Development of Cell Culture-based Live Attenuated Influenza Vaccine, Jonathan Liu, Luis Maranga, Sachin Mani, and Richard Schwartz (Article)
Analytical and Manufacturing Challenges in Preparation of Bacterial Polysaccharide Conjugates, Carl Frasch (Article)
Development of Validated Assays for Measuring the Human Antibody Response to Polysaccharide Conjugate Vaccines, Helena Käyhty (Article)
Development of Vaxfectin®-adjuvanted DNA Vaccines, Alain Rolland (Article)
Well-Characterized Adenoviral Vector-Based Vaccines: Are We There Yet?, Katey Einterz Owen (Article)
Focus on Aggregation: Causes, Impact & Characterization, John Philo (Article)
RSV Vaccine Using Recombinant F protein?, Sophie Nallet (Article)
A Selective Recovery Methodology for the Primary Purification of Lipid Envelope Virus-Like Particles from S. cerevisiae, Gaik Sui Kee, Hari Pujar, and Nigel Titchener-Hooker (Article)
Trouble-Shooting Fermentation and Primary Recovery Manufacturing Issues in Order to Optimize Antigen Expression for the Vaccine Business, Tim Lee (Article)
Vaccine Development for Developing Countries – Regulatory Approach in the European Union, Manfred G. Haase (Article)
Developing Vaccines for Neglected Diseases, Douglas Holtzman (Article)
Challenge of Filing 4 New Vaccines at Once – Lessons Learned, Keith Chirgwin (Article)
Process Intensification for Large Scale Manufacturing Issues, J.C. Drugmand, N. Havelange, N. Alaoui, and J. Castillo (Article)
Vaccine Technology II: Abstracts of Oral Presentations, The Editors (Article)
Vaccine Technology II: Abstracts of Poster Presentations, The Editors (Article)
Emerging Diseases, Zoonoses and Vaccines to Control Them, Paul-Pierre Pastoret (Article)